Bendroflumethiazide

Land: Nya Zeeland

Språk: engelska

Källa: Medsafe (Medicines Safety Authority)

Aktiva substanser:

Bendroflumethiazide 2.5mg;  ;  

Tillgänglig från:

Ipca Pharma (NZ) Pty Limited

INN (International namn):

Bendroflumethiazide 2.5 mg

Dos:

2.5 mg

Läkemedelsform:

Tablet

Sammansättning:

Active: Bendroflumethiazide 2.5mg     Excipient: Lactose Purified talc Starch Stearic acid

Enheter i paketet:

Blister pack, PVC/PVDC, 14 tablets

Klass:

Prescription

Receptbelagda typ:

Prescription

Tillverkad av:

Ipca Laboratories Limited

Terapeutiska indikationer:

Bendrofluazide is indicated in the treatment of oedema associated with conditions such as: congestive heart failure, nephrotic syndrome and cirrhosis of the liver.

Produktsammanfattning:

Package - Contents - Shelf Life: Blister pack, PVC/PVDC - 14 tablets - 24 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC - 28 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE - 500 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE - 1000 tablets - 24 months from date of manufacture stored at or below 25°C

Tillstånd datum:

2006-06-28